Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
GNI Group Ltd
2160Current price
3 045 JPY
-103.56 JPY (-3.33%)
Last closed
3 080 JPY
Company
www.gnipharma.com
ISIN
JP3386370005
Sector
Healthcare
Industry
Biotechnology
Exchange
Tokyo Stock Exchange
Capitalization
157 756 112 223 JPY
Yield for 12 month
+21.75 %
1Y
3Y
5Y
10Y
15Y
2160
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, it is involved in developing F351, which is in Phase III clinical trial for the treatment of liver fibrosis; and F573 that is in phase II for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan. Address: Nihonbashi-Honcho YS Building, Tokyo, Japan, 103-0023
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
594 189.9 JPYP/E ratio
22.8896Dividend Yield
–Current Year
+26 106 233 775 JPY
Last Year
+17 483 030 264 JPY
Current Quarter
+5 806 529 304 JPY
Last Quarter
+5 970 446 853 JPY
Current Year
+22 513 673 337 JPY
Last Year
+14 798 785 090 JPY
Current Quarter
+4 854 343 070 JPY
Last Quarter
+4 748 893 654 JPY
Key Figures 2160
1 year
3 years
5 years
10 years
EBITDA
1 549 678 599 JPY
Operating Margin TTM
PE Ratio
22.8896
Return On Assets TTM
0.87 %
PEG Ratio
–
Return On Equity TTM
16.83 %
Wall Street Target Price
594 189.9 JPY
Revenue TTM
23 733 970 509 JPY
Book Value
738.55 JPY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-41.5 %
Dividend Yield
–
Gross Profit TTM
14 798 226 103 JPY
Earnings per share
137.68 JPY
Diluted Eps TTM
137.68 JPY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
36.8 %
Profit Margin
28.61 %
Dividend Analytics 2160
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2160
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
3:1
Payout Ratio
–
Last Split Date
02.09.2019
Dividend Date
–
Stock Valuation 2160
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
22.8896
Forward PE
–
Enterprise Value Revenue
5.7805
Price Sales TTM
6.6468
Enterprise Value EBITDA
12.2761
Price Book MRQ
4.1244
Financials 2160
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2160
For 52 weeks
1 542.65 JPY
3 879.21 JPY
50 Day MA
2 731.03 JPY
Shares Short Prior Month
–
200 Day MA
2 594.75 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart